Table 5. Types of pharmacists’ interventions performed during medication review with follow-up.
| Intervention | Month 1 (n=688) | Month 2 (n=669) | Month 3 (n=662) | Month 4 (n=661) | Month 5 (n=654) | Month 6 (n=646) |
|---|---|---|---|---|---|---|
| Proposal to general practitioner | ||||||
| Dose modification | 25 (7.1%) | 34 (8.6%) | 23 (8.3%) | 18 (8.4%) | 16 (8.1%) | 8 (7.6%) |
| Dosage modification | 18 (5.1%) | 21 (5.3%) | 11 (4.0%) | 8 (3.7%) | 9 (4.6%) | 4 (3.8%) |
| Schedule modification | 13 (3.7%) | 13 (3.3%) | 13 (4.7%) | 6 (2.8%) | 3 (1.5%) | 1 (1.0%) |
| Adding a medication | 44 (12.5%) | 52 (13.2%) | 43 (15.6%) | 46 (21.5%) | 42 (21.3%) | 19 (18.1%) |
| Medication withdrawal | 25 (7.1%) | 33 (8.4%) | 19 (6.9%) | 9 (4.2%) | 9 (4.6%) | 5 (4.8%) |
| Medication substitution | 64 (18.2%) | 77 (19.5%) | 71 (25.7%) | 47 (22%) | 47 (23.9%) | 24 (22.9%) |
| Referral with no specific proposal | 22 (6.3%) | 20 (5.1%) | 10 (3.6%) | 16 (7.5%) | 19 (9.6%) | 14 (13.3%) |
| Patient health education | ||||||
| Use and medicine administration | 29 (8.2%) | 23 (5.8%) | 16 (5.8 %) | 9 (4.2%) | 7 (3.6%) | 7 (6.7%) |
| Medication adherence | 71 (20.2%) | 57 (14.5%) | 33 (12%) | 28 (13.1%) | 25 (12.7%) | 17 (16.2%) |
| Non-pharmacological advice | 75 (21.3%) | 103 (26.1%) | 70 (25.4%) | 53 (24.8%) | 43 (21.8%) | 25 (23.8%) |
| Total number of interventions | 365 | 413 | 339 | 229 | 215 | 115 |